Efficacy differences between tocilizumab and ketogenic diet during acute phase of febrile Infection-Related epilepsy syndrome in children: A retrospective cohort study

Key Points

• Efficacy differences were noted between tocilizumab and ketogenic diet in managing febrile infection-related epilepsy syndrome in children.
• The trend shows that children receiving the ketogenic diet had a significant reduction in seizure frequency compared to those on tocilizumab treatment.
• Observational analysis of past cases involving febrile infection-related epilepsy syndrome highlights notable treatment outcomes.
• Findings suggest the ketogenic diet might be a more effective intervention in the acute phase, indicating a need for further research.